Twitter Facebook LinkedIn
Center for Global Research Data

Blog

View: All | News | Blog | Events


Vivli Board Member Dr. Stewart recently connected with researchers Prof. José António P. Da Silva and Dr. Ricardo J.O. Ferreira from the University of Coimbra to discuss the value of clinical trials, data sharing and specifically what we’ve learned about advances in rheumatology. Dr. Ferreira and Prof. Da Silva used the Vivli platform to request...  > MORE
There are more than 7,000 rare diseases and of those 90% are without an FDA-approved treatment. Sharing rare disease data is difficult for a number of reasons, including concerns around protecting patient privacy, control of the data and managing competition, and the possibility for misinterpretation of data. Recently CureDuchenne, Vivli, and the Rare Disease Cures Accelerator-Data...  > MORE
In 2018, Vivli launched its first data analysis challenges to encourage researchers to search and request studies available on the Vivli platform. Since then, we have had received more than 250 requests. Early last year, Vivli was excited to name ten Pioneer Winners – the first lead investigators whose data requests were successfully approved—and its...  > MORE
  Vivli has waived fees associated with data contributions from academic researchers located in low-and-middle-income countries. “We decided to waive these fees as it was important to remove financial barriers to data sharing,” said Rebecca Li, Executive Director of Vivli. Learn more about the process in How to Share Data. For researchers that have any questions,...  > MORE
Center for Biomedical Research Transparency (CBMRT) is hosting its fourth annual global summit series with the intention to engage a diverse group of participants with a passion for increasing transparency in research practices. CBMRT will host a virtual Summit series with short sessions scheduled for February 26, March 16 and March 26. Participants can expect...  > MORE
Vivli is delighted to launch the first in a series of training videos aimed at researchers interested in accessing individual participant level data (IPD). These short and informative data sharing videos can help a first-time requester of data or a more experienced secondary analysis researcher. Topics include: • What is typically provided in the data...  > MORE
Vivli Executive Director, Rebecca Li, will join Critical Path Institute’s Jane Larkindale and Debra Miller from CureDuchenne for a session on Data Sharing of Rare Disease Data – Challenges and Rewards at the PHUSE Data Transparency Winter Meeting. This live presentation can be viewed on Tuesday 19th January 2021 between 15:00–17:30 GMT (10:00 am –...  > MORE
We are delighted to share with you Vivli’s 2020 Progress Report, which highlights our milestones to date and plans for the year ahead. We look forward to continuing to grow together in 2021 and beyond, as leaders in data sharing and transparency, working together towards our end goal of advancing human health.  > MORE
Vivli Co-Founder Dr. Ida Sim will lead a dkNET webinar entitled “Vivli: A Global Clinical Trials Data Sharing Platform”. dkNET is a search portal that helps researchers find research resources relevant to their research and keep up to date on new tools, services and mandates to support robust and reproducible science. In this webinar, Dr....  > MORE
“Vivli Global Researchers and Key Stakeholders – Creating Impact” On November 10th, we gathered for a lively discussion as part of our 2020 Annual Meeting. The meeting created a dialogue between researchers and data contributors about data sharing and what can be done to further increase scientific knowledge in future. VIEW THE RECORDING Agenda Welcome...  > MORE
“We are delighted that AstraZeneca is joining as a Vivli member and making it possible for researchers to access the data from their clinical trials,” said Rebecca Li, Vivli Executive Director. AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases...  > MORE
Vivli is excited to announce it’s newest publication entitled Timely access to trial data in the context of a pandemic: the time is now. The article, published in BMJ Open, highlights how Vivli is addressing the needs of the COVID-19 challenge and demonstrates how the sharing of data collected from each trial participant enables combining of...  > MORE
“Vivli Global Researchers and Key Stakeholders – Creating Impact” On November 10th, we gathered for a lively discussion as part of our 2020 Annual Meeting. The meeting created a dialogue between researchers and data contributors about data sharing and what can be done to further increase scientific knowledge in future. VIEW THE RECORDING Agenda Welcome...  > MORE
Vivli Executive Director, Rebecca Li, will take part in a panel discussion next week as part of Northeastern University’s Center for Law, Innovation and Creativity Annual Conference. The virtual conference, entitled This is What Democracy Looks Like – Exploring the Future of Governance Through Intellectual Property and Technology Regulation, will be held on Friday, October 16th...  > MORE
Vivli’s Director of Strategy and Operations, Julie Wood, will be presenting at the 2020 European Medical Writers Association 2020 Virtual Symposium on 6 November 2020. The event’s theme is Research Integrity & The Medical Communicator: What We Do When Know One is Watching. Wood’s talk is entitled Responsible Data-Sharing to Improve Research Integrity. The full agenda...  > MORE
September 3 at 11AM ET This 60-minute webinar will explore the emergence of synthetic data, a privacy preservation approach to protect individual patient data. Top experts will explain what synthetic data is, when and how to deploy this approach and share case studies about the successful utilization of using synthetic data and future applications of...  > MORE
Vivli Executive Director, Rebecca Li, will take part in a panel discussion as part of Data Sharing to Accelerate Therapeutic Development for Rare Diseases hosted by Duke and the FDA. Her session will focus on platform analytics tools to support data sharing and drug development for rare diseases. The Duke-Margolis Center for Health Policy, through...  > MORE
Vivli extends a warm welcome to our newest member, Mitsubishi Tanabe Pharma. “We are delighted to include Mitsubishi Tanabe studies on the Vivli platform,” said Rebecca Li, Vivli Executive Director. “By joining Vivli, Mitsubishi Tanabe will help drive scientific discovery through data sharing to advance human health.” As a global research-driven pharmaceutical company, Mitsubishi Tanabe...  > MORE
“We are delighted to welcome Taiho Pharma as a member of Vivli and to be able to partner with them to manage requests received for their individual patient-level data from completed clinical trials,” said Rebecca Li, Vivli Executive Director. Taiho Pharma is an R&D-driven specialty pharma focusing on the three fields of oncology, allergies and...  > MORE
Members of Vivli, the Center for Clinical Research Data, announce today their commitment to share their COVID-19 trials through Vivli. Members who have committed to sharing their data on the COVID-19 portal, a dedicated search function within Vivli for COVID-19 include Eli Lilly & Company, Regeneron, Roche, Takeda. Additionally, Cochrane, Covid Collaboration Platform, UCB, and...  > MORE
REGISTER NOW Join Vivli, COVID Collaboration Platform (CP) and TransCelerate BioPharma for a discussion of how these organizations are working to support academia, foundations and industry to collaborate and share data for COVID-19 trials. The webinar will discuss the work that each organization is taking to support their stakeholders to more quickly collaborate, share and...  > MORE
“We are thrilled to welcome Roche as a member of Vivli and to be able to list their studies on the platform,” said Rebecca Li, Vivli Executive Director. Roche is a global health care leader in the areas of oncology, immunology, infectious diseases and neuroscience. Through innovation in diagnostics and targeted treatments, Roche aims to...  > MORE
Regeneron joins Vivli, reinforcing their commitment to data transparency “We are pleased to welcome Regeneron as a member of Vivli,” said Rebecca Li, Vivli Executive Director. “Regeneron is acting on its commitment to drive forward scientific discovery and advance human health by sharing individual patient-level clinical data from certain completed trials with approved researchers.” Regeneron...  > MORE
Access to data from completed coronavirus trials would be made available to all qualified researchers Cambridge, MA–In a visible sign of data sharing leadership, Vivli, the Center for Clinical Research Data, has committed to serving the open science community through the launch of a COVID-19 portal for sharing of completed interventional treatment trial data. All...  > MORE
Dr. John Frew, the first Pioneer Award winner, from Rockefeller University, sat down for an interview with Vivli to share more about his research, the impact his findings are having on future clinical trial design and patient care, as well as his advice to researchers who were going to embark on a research project using...  > MORE
Vivli launched its first data analysis challenge shortly after our launch in an effort to generate interest and move data sharing forward. We are delighted to announce the first Vivli Global Data Sharing Innovator and our Vivli Pioneer Winners. John Frew, Rockefeller University, is the first Global Data Sharing Innovator for his publication in the...  > MORE
VIEW HERE Join Vivli for a webinar discussing the differences between Real-World Data (RWD) and Real-World Evidence (RWE), and clinical trials. Different types of study designs can help answer different questions and this webinar will explore when these different approaches are deployed. The panelists will provide an overview of the RWD and RWE landscape, the...  > MORE
We are delighted to share with you Vivli’s 2019 Progress Report, which highlights our milestones to date and plans for the year ahead. We look forward to continuing to grow together in 2020 and beyond, as leaders in data sharing and transparency, working together towards our end goal of advancing human health.  > MORE
Few things are more frustrating than wasted time. The Vivli team wants to help you make the most of your valuable time, and to help make sure that your data request has the best possible chance for success. While access to data is a decision made by our data contributors (see our Members Page for...  > MORE
“We are delighted to have Johnson & Johnson join Vivli as a member,” said Rebecca Li, Vivli Executive Director. “This partnership will drive science forward by enabling the combination of J&J data with sources available from Vivli’s other member organizations.” Read more about the partnership in this post by Joanne Waldstreicher, Chief Medical Officer at...  > MORE
Long-term cancer survivor and patient advocate Jane Perlmutter tells us why data sharing is so important for people with rare diseases. Q: Why should we share data from clinical trials?  Jane Perlmutter: I spent half my life as a cancer survivor. At first, I thought I wouldn’t survive it–and I’ve had three more cancer diagnoses...  > MORE
By Rebecca Li, Vivli Executive Director I started my career at a small biotech company and understand the intensity of the start-up experience as well as the experience of the more mature mid-size biotech and pharma company. Data sharing can be an after-thought to the challenges of bringing treatments to the clinic. We at Vivli...  > MORE
 In June of 2017, the International Committee of Medical Journal Editors, or ICMJE, released new requirements for data sharing statements, for submissions to their publications. The ICMJE represents the most well-respected and influential publications in the biosciences, including the New England Journal of Medicine; the Lancet; Annals of Internal Medicine; the BMJ; and PLOS Medicine: These publications, and the many others which...  > MORE
January 7, 2019 | What is IPD meta-analysis?
Meta-analysis is a statistical technique for combining sources of quantitative evidence. It is an example of secondary analysis, which is a subsequent analysis of clinical trial data. The original, or primary analysis of the data was for the purpose that the data was collected – with regards to the data presently shared on Vivli, a...  > MORE
Ida Sim, Technical Lead, Vivli As increasing numbers of funders introduce requirements for data sharing plans, researchers have to develop a new skill: how to create and fulfill a data sharing plan. Many data sharing plan requirements from funders have similar requirements. While the specifics vary somewhat based upon the type of data and how...  > MORE
Vivli is an innovative new clinical research data sharing platform with a robust search engine that has been created to meet the needs of researchers worldwide who use clinical research data. Using the Vivli platform, researchers can access anonymized data from more than 7,000 completed clinical trials. My mission at Vivli is to lead the...  > MORE